Abstract
At probenecid levels greater than 10 μg/ml, CSF cAMP was independent of CSF probenecid concentration. At these levels of probenecid, cAMP transport out of CSF is probably maximally blocked and cAMP levels reflect cAMP release into CSF. CSF cAMP was significantly higher in RDC-diagnosed schizophrenics than in other psychotics or depressives. A significant decrease in CSF cAMP was found in psychotic patients treated with chlorpromazine. No changes in CSF cAMP were observed in patients treated with tricyclic antidepressants or lithium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angel, C., De Luca, D. C., Murphree, O. D.: Probenecid-induced accumulation of cyclic nucleotides, 5HJAA, and HVA in cisternal spinal fluid of genetically nervous dogs. Biol. Psychiatry 11, 543–753 (1976)
Ashcroft, G. W., Sharman, D. F.: 5-Hydroxyindoles in human cerebrospinal fluids. Nature 186, 1050–1051 (1960)
Biederman, J., Rimon, R., Ebstein, R., Belmaker, R. H.: Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patients. Neuropsychobiology 2, 324–327 (1977b)
Biederman, J., Rimon, R., Ebstein, R., Belmaker, R. H., Davidson, J. T.: Cyclic AMP in the CSF of patients with schizophrenia. Br. J. Psychiatry 130, 64–67 (1977a)
Bowers, M. B., Jr.: Central dopamine turnover in schizophrenic syndromes. Arch. Gen. Psychiatry 31, 50–54 (1974)
Bowers, M. B., Jr.: Clinical measurement of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of CSF acid monoamine metabolite measures. Neuropharmacology 11, 101–111 (1972a)
Bowers, M. B., Jr.: CSF 5HIAA and HVA following probenecid in unipolar depressives treated with amitriptyline. Psychopharmacologia (Berl.) 23, 26–33 (1972b)
Brown, B. L., Albano, J. D. M., Ekins, R. P., Sgherzi, A. M.: A simple and sensitive saturation assay method for the measurement of adenosine 3′5′-cyclic monophosphate. Biochem. J. 121, 561–562 (1971)
Cramer, H., Goodwin, F. K., Post, R. M., Bunney, W. E., Jr.: Effects of probenecid and exercise on CSF cyclic AMP in affective illness. Lancet 1972a I, 1346–1347
Cramer, H., Ng, L. K. Y., Chase, T. N.: Effect of probenecid on levels of cyclic AMP in human cerebrospinal fluid. J. Neurochem. 19, 1601–1602 (1972b)
Dencker, S. J., Malm, U., Roos, B. E., Werdinius, B.: Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem. 13, 1545–1548 (1966)
Forrest, J. N., Jr.: Lithium inhibition of cyclic AMP-mediated hormones: a caution. N. Engl. J. Med. 292, 423–424 (1975)
Gerbode, F. A., Bowers, M. B., Jr.: Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid. J. Neurochem. 15, 1053–1055 (1968)
Gordon, E. K., Oliver, J.: 3-Methoxy-4-hydroxyphenylethylene glycol in human cerebrospinal fluid. Clin. Chim. Acta 35, 145–150 (1971)
Kebabian, J. W., Greengard, P.: Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission. Science 174, 1346–1349 (1971)
Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine-sensitive adenylate cyclase in the caudate nucleus of the rat brain and its similarity to the “dopamine receptor”. Proc. Natl. Acad. Sci. USA 69, 2145–2149 (1972)
Kababian, J. W., Bloom, F. E., Steiner, A. L., Greengard, P.: Neurotransmitter-induced increases in cyclic nucleotides in post-ganglionic neurons in mammalian sympathetic ganglion: Immunocytochemical demonstration. Science 190, 157–160 (1975)
Korf, J., Boer, P. H., Fekkes, D.: Release of cerebral cyclic AMP into push-pull perfusates in freely moving rats. Brain Res. 113, 551–561 (1976)
Korf, J., van Praag, H. M.: Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Res. 35, 221–230 (1971)
Korf, J., van Praag, H. M., Sebens, J. B.: Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic and, and 3-methoxy 4-hydroxyphenylglycol in cerebrospinal fluid. Biochem. Pharmacol. 20, 659–668 (1971)
Krueger, B. K., Forn, J., Walters, J. R., Roth, R. H., Greengard, P.: Stimulation by dopamine of adenosine 3′5′-monophosphate formation in rat caudate nucleus: effect of lesions of the nigroneostriatal pathway. Mol. Pharmacol. 12, 639–648 (1976)
Myllylä, V. V., Heikkinen, E. R., Simllä, S., Hokkanen, E., Vapaatalo, H.: CSF concentration and urinary excretion of cyclic adenosine 3′5′-monophosphate in various diseases of children. Z. Kinderheilkd. 118, 259–264 (1975b)
Myllylä, V. V., Heikkinen, E. R., Vapaatalo, H., Hokkanen, E.: Cyclic AMP concentration and enzyme activities of CSF in patients with epilepsy or central nervous system damage. Eur. Neurol. 13, 123–130 (1975a)
Olsson, R., Roos, B. E.: Concentration of 5-hydroxyindole acetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature 219, 502–503 (1968)
Pandey, G. N., Garver, D. L., Tamminga, C., Ericksen, S., Ali, S. I., Davis, J. M.: Postsynaptic supersensitivity in schizophrenia. Am. J. Psychiatry 134, 518–522 (1977)
Perry, J.: 3′-5′ Cyclic adenosine monophosphate concentration in CSF of patients with prolonged coma. N. Engl. J. Med. 296, 56 (1977)
Perel, J., Levitt, M., Dunner, D. L.: Plasma and CSF probenecid concentrations as related to accumulation of acidic biogenic amine metabolites in man. Psychopharmacologia (Berl.) 35, 83–90 (1974)
Post, R. M., Goodwin, F. K.: Time-dependent effects of phenothiazine on dopamine turnover in psychiatric patients. Science 190, 488–489 (1975)
Robison, G. A., Coppen, A. J., Whybrow, P. C., Prange, A. J.: Cyclic AMP in affective disorders. Lancet 1970 II, 1028–1029
Rudman, D., Fleischer, A., Kutner, M. H.: Concentrations of 3′,5′ cyclic adenosine monophosphate in ventricular CSF of patients with prolonged coma after head trauma or intracranial hemorrhage. N. Engl. J. Med. 295, 635–638 (1976)
Schultz, J., Daly, J. W.: Adenosine 3′,5′-monophosphate in guinea pig cerebral cortical slices: Effects of α-and β-adrenergic agents, histamine, serotonin, and adenosine. J. Neurochem. 21, 573–579 (1973)
Sebens, J. B., Korf, J.: Cyclic AMP in cerebrospinal fluid: accumulation following probenecid and biogenic amines. Exp. Neurol. 46, 333–344 (1975)
Siggins, G. R., Haffer, B. J., Bloom, F. E.: Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. III. Evidence for mediation of norepinephrine effects by cyclic 3′,5′-adenosine monophosphate. Brain Res. 25, 535–553 (1971)
Sjöstrom, R.: Steady state levels of probenecid and their relation to acid monoamine metabolites in human CSF. Psychopharmacologia (Berl.) 25, 96–100 (1972)
Smith, C. C., Tallman, J. F., Post, R. M., van Kammen, D. P., Jimerson, D. C., Brown, G. L., Brooks, B. R., Bunney, W. E., Jr.: An examination of baseline and drug-induced levels of cyclic nucleotides in the CSF of control and psychiatric patients. Life Sci. 19, 131–136 (1976)
Spitzer, R. L., Endicott, J., Robins, E.: Research diagnostic criteria. Arch. Gen. Psychiatry 35, 773–785 (1978)
Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397–1408 (1970)
Wode-Helgodt, B., Fyrö, B., Gullberg, B., Sedvall, G.: Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients. Acta Psychiatr. Scand. 56, 129–142 (1977)
Zohar, J., Biederman, J., Rimon, R., Ebstein, R., Belmaker, R.: Clinical correlates of CSF cyclic nucleotides in schizophrenia. Am. J. Psychiatry 135, 253–255 (1978)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bowers, M.B., Study, R.E. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: Studies in psychiatric patients. Psychopharmacology 62, 17–22 (1979). https://doi.org/10.1007/BF00426029
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426029